INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

47 hedge funds and large institutions have $149M invested in Inozyme Pharma in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 15 closing their positions.

Holders
47
Holders Change
-3
Holders Change %
-6%
% of All Funds
0.79%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
13
Increased
18
Reduced
14
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DTC
1
Deep Track Capital
Connecticut
$15.5M
2
VA
2
VR Adviser
New York
$12.9M
3
SI
3
Sofinnova Investments
California
$17.4M
4
RSCM
4
Rock Springs Capital Management
Maryland
$12.6M
5
SFM
5
Sphera Funds Management
Israel
$5.56M

Top Sellers

1
SCM
1
Suvretta Capital Management
New York
$0
2
BlackRock
2
BlackRock
New York
$2.05M
3
State Street
3
State Street
Massachusetts
$234K
4
Northern Trust
4
Northern Trust
Illinois
$224K
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SI
1
Sofinnova Investments
California
$17.4M 3,655,308 +1,627,000 +80%
DTC
2
Deep Track Capital
Connecticut
$15.5M 3,250,000 +3,250,000 New
VA
3
VR Adviser
New York
$12.9M 2,709,987 +2,709,987 New
DM
4
Deerfield Management
New York
$12.9M 2,696,372 +351,586 +15%
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$12.7M 2,661,154 +1,070,000 +67%
RSCM
6
Rock Springs Capital Management
Maryland
$12.6M 2,640,056 +1,446,861 +121%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$12.1M 2,546,672 +800,000 +46%
NMC
8
NEA Management Company
Maryland
$10.5M 2,444,379 – –
CA
9
CHI Advisors
New York
$9.7M 2,033,802 +1,141,745 +128%
Vanguard Group
10
Vanguard Group
Pennsylvania
$6.46M 1,354,216 +864,603 +177%
SFM
11
Sphera Funds Management
Israel
$5.56M 1,165,600 +1,165,600 New
Janus Henderson Group
12
Janus Henderson Group
United Kingdom
$4.46M 929,956 +409,193 +79%
MB
13
MPM BioImpact
Massachusetts
$3.17M 664,980 +370,000 +125%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$2.91M 609,819 +225 +0%
BlackRock
15
BlackRock
New York
$2.05M 430,520 -447,880 -51%
LCM
16
Laurion Capital Management
New York
$1.3M 271,800 +261,800 +2,618%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1.03M 216,925 +30,918 +17%
Millennium Management
18
Millennium Management
New York
$826K 173,092 +173,092 New
UOC
19
UBS O'Connor
Illinois
$817K 171,347 +171,347 New
Citadel Advisors
20
Citadel Advisors
Florida
$577K 120,827 +22,530 +23%
Renaissance Technologies
21
Renaissance Technologies
New York
$564K 118,300 +106,400 +894%
BBA
22
Baker Bros. Advisors
New York
$510K 106,999 – –
Walleye Capital
23
Walleye Capital
New York
$484K 101,442 +101,442 New
BCM
24
Bridgeway Capital Management
Texas
$417K 87,400 +30,000 +52%
OMC
25
Overbrook Management Corp
New York
$331K 69,326 +52,600 +314%
1
2 3